Many studies show that an imbalance between Bax and Bcl-2, with increased levels of Bax and decreased levels of Bcl-2, affects lymphocytes proliferation and survival (such as Th, B, and NK cells) in patients with cancer.18,20. This evidence concerns the gene BCL2 and cancer.